Evaxion A/S (NASDAQ:EVAX – Get Free Report) and Healthcare Triangle (NASDAQ:HCTI – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.
Insider and Institutional Ownership
11.0% of Evaxion A/S shares are owned by institutional investors. Comparatively, 0.3% of Healthcare Triangle shares are owned by institutional investors. 41.6% of Evaxion A/S shares are owned by company insiders. Comparatively, 0.1% of Healthcare Triangle shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares Evaxion A/S and Healthcare Triangle”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Evaxion A/S | $7.53 million | 3.69 | -$7.71 million | ($1.47) | -2.27 |
| Healthcare Triangle | $13.89 million | 0.34 | -$9.48 million | ($66.69) | -0.03 |
Evaxion A/S has higher earnings, but lower revenue than Healthcare Triangle. Evaxion A/S is trading at a lower price-to-earnings ratio than Healthcare Triangle, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Evaxion A/S and Healthcare Triangle’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Evaxion A/S | N/A | -73.56% | -37.45% |
| Healthcare Triangle | -70.43% | -166.88% | -43.00% |
Analyst Recommendations
This is a breakdown of current ratings and price targets for Evaxion A/S and Healthcare Triangle, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Evaxion A/S | 1 | 0 | 5 | 0 | 2.67 |
| Healthcare Triangle | 1 | 0 | 0 | 0 | 1.00 |
Evaxion A/S presently has a consensus price target of $11.00, suggesting a potential upside of 229.84%. Given Evaxion A/S’s stronger consensus rating and higher possible upside, research analysts clearly believe Evaxion A/S is more favorable than Healthcare Triangle.
Volatility & Risk
Evaxion A/S has a beta of 0.24, suggesting that its share price is 76% less volatile than the S&P 500. Comparatively, Healthcare Triangle has a beta of 1.04, suggesting that its share price is 4% more volatile than the S&P 500.
Summary
Evaxion A/S beats Healthcare Triangle on 11 of the 14 factors compared between the two stocks.
About Evaxion A/S
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of metastatic melanoma; EVX-02, a DNA-based vaccine that is in Phase 1/2a trial designed to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, DNA-based cancer vaccine for the treatment of various cancers. Its programs also include some vaccines that are in pre-clinical stage, which includes EVX-B1 for the prevention of S. aureus-induced skin and soft tissue infections in patients undergoing elective abdominal hernia surgery; EVX-B2 to target diseases caused by N. gonorrhoeae; EVX-B3 for eliciting strong humoral antibody and cellular immune response to the bacterial pathogen; and EVX-V1, viral vaccine product candidate for targeting Cytomegalovirus. Evaxion Biotech A/S was incorporated in 2008 and is based in Horsholm, Denmark.
About Healthcare Triangle
Healthcare Triangle, Inc., a healthcare information technology company, focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record, and healthcare and life sciences industry. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and accelerate their digital transformation. The company’s software platforms include CloudEz, an enterprise multi-cloud transformation and management platform that enables customers to manage their cloud infrastructure in private, hybrid, and public cloud infrastructures; and DataEz, a cloud-based data analytics and data science platform for the data analytics and data science requirements of life sciences/pharmaceutical and healthcare provider organizations. It also provides Readabl.AI, a Software-as-a-Service solution that uses public cloud artificial intelligence and machine learning to recognize and extract healthcare information from documents, faxes, and narrative reports. In addition, the company offers cloud IT services; and healthcare IT services, such as electronic health records and software implementation, optimization, and extension to community partners, as well as application managed services, and backup and disaster recovery on public cloud. It primarily serves healthcare delivery organizations, healthcare insurance companies, pharmaceutical and life sciences, biotech companies, and medical device manufacturers. The company was incorporated in 2019 and is based in Pleasanton, California. Healthcare Triangle, Inc. is a subsidiary of SecureKloud Technologies, Inc.
Receive News & Ratings for Evaxion A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evaxion A/S and related companies with MarketBeat.com's FREE daily email newsletter.
